Colgate-Palmolive Company (NYSE:CL) finished Friday with an addition of $0.51 to close at $73.83, an upside of 0.70 percent. An average of 3,045,040 shares of common stock have been traded in the last five days. There was a fall of -$0.72 in the past week, and it reached a new high 5 times over the past 12 months. The last 20 days have seen an average of 3,781,690 shares traded, while the 50-day average volume stands at 4,656,602.
CL stock has decreased by -4.25% in the last month. The company shares reached their 1-month lowest point of $73.13 on 08/23/23. With the stock rallying to its 52-week high on 05/15/23, shares of the company touched a low of $67.84 and a high of $82.09 in 52 weeks. It has reached a new high 7 times so far this year and lost -6.30% or -$4.96 in price. In spite of this, the price is down -10.06% from the 52-week high.
Insider Transactions
CL stock investors should be aware that Colgate-Palmolive Company (CL) stock had its last reported insider trading activity 24 days ago on Aug 02. In this transaction, the insider spent $1,684,062. CLO and Secretary, Daniels Jennifer, disposed of 24,703 shares at a price of $79.70 on May 19. The insider now owns more than $1,968,930 worth of shares. Prior to that, Chief Human Resources Officer Massey Sally went on to Sale 14,594 shares at $81.55 each on May 15. An amount of $1,190,141 was transacted.
Valuation Metrics
Colgate-Palmolive Company (CL) has a trailing price-to-earnings (P/E) ratio of 41.18. The stock’s beta is 0.49. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.24, and the price-to-cash flow ratio at 25.71.
The company has a payout ratio of 105.10%. The company’s most recent quarterly dividend payment was $0.48 a share, without any change from last year. Its latest increase dividend $0.01 reported on Thursday March 9 2023.
Financial Health
The quick ratio of Colgate-Palmolive Company for the three months ended June 29 was 0.70, and the current ratio was 1.20, indicating that the company is not able to meet its debt obligations. Colgate-Palmolive Company’s EBITDA margin for the year ending June 29 is 22.99%, while its operating margin for the same period stands at 14.80%. Its gross profit as reported stood at $10.25 billion compared to revenue of $17.97 billion.
Earnings Surprise
For the three-month period that ended June 29, Colgate-Palmolive Company had $8.95 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $502.0 million in the quarter, while revenues were shrunk -20.12%. The analyst consensus anticipated Colgate-Palmolive Company’s latest quarter earnings to come in at $0.75 per share, but it turned out to be $0.77, a 2.70% surprise. For the quarter, EBITDA amounted to $1.12 billion. Shareholders own equity worth $826.69 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Colgate-Palmolive Company (CL) price momentum. RSI 9-day as of the close on 25 August was 37.46%, suggesting the stock is Neutral, with historical volatility in this time frame at 10.38%.
As of today, CL’s price is $73.59 -0.97% or -$0.72 from its 5-day moving average. CL is currently trading -2.37% lower than its 20-day SMA and -2.03% lower than its 100-day SMA. However, the stock’s current price level is -2.11% below the SMA50 and +0.45% above the SMA200.
The stochastic %K and %D were 10.43% and 8.81%, respectively, and the average true range (ATR) was 1.01. With the 14-day stochastic at 17.26% and the average true range at 1.05, the RSI (14) stands at 38.99%. The stock has reached -0.40 on the 9-day MACD Oscillator while the 14-day reading was at -1.25.
Analyst Ratings
Citigroup launched coverage on Colgate-Palmolive Company (NYSE: CL) in its analyst report released on February 17, 2023. The firm assigned the stock a Buy rating. The consensus rating for Colgate-Palmolive Company (CL) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell CL, while 12 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 9 others rate it as a “buy”.
What is CL’s price target for the next 12 months?
Analysts predict a range of price targets between $68.00 and $98.00, with a median target of $85.00. Taking a look at these predictions, the average price target given by analysts for Colgate-Palmolive Company (CL) stock is $85.40.
